Cyclophosphamide "metronomic" chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer | BMC Cancer | Full Text
Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate innate immunity and drive potent T... | Oncotarget
Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM) -
Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate | British Journal of Cancer
A Dose-finding Study of Metronomic Oral Vinorelbine in Combination With Oral Cyclophosphamide and Bevacizumab in Patients With Advanced Breast Cancer - Clinical Breast Cancer
IJMS | Free Full-Text | Low Dose Cyclophosphamide Modulates Tumor Microenvironment by TGF-β Signaling Pathway | HTML
Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers | EMBO Molecular Medicine
Unexpected benefit from an 'old' metronomic chemotherapy regimen in advanced chordoma | BMJ Case Reports
Low-dose metronomic cyclophosphamide treatment mediates ischemia-dependent K-ras mutation in colorectal carcinoma xenografts | Oncogene
Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer | npj Breast Cancer
Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion | PLOS ONE
Metronomic chemotherapy of thalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients - Clinical Lymphoma, Myeloma and Leukemia
A) Single low-dose cyclophosphamide is superior to metronomic... | Download Scientific Diagram
Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity - Annals of Oncology
Metronomic oral cyclophosphamide in relapsed ovarian cancer | International Journal of Gynecologic Cancer
Metronomic Chemotherapy: Direct Targeting of Cancer Cells after all?: Trends in Cancer
Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer | npj Breast Cancer
Metronomic chemotherapy in breast cancer | Semantic Scholar
Metronomic cyclophosphamide: An alternative treatment for hepatic epithelioid hemangioendothelioma - Journal of Hepatology
Oral Metronomic Cyclophosphamide with and without Methotrexate as Palliative Treatment for Patients with Metastatic Breast Carcinoma | Anticancer Research
Low-dose metronomic cyclophosphamide treatment mediates ischemia-dependent K-ras mutation in colorectal carcinoma xenografts | Oncogene
Metronomic Chemotherapy - Ethos Veterinary Health
Effects of sunitinib, lenalidomide, and metronomic cyclophosphamide on... | Download Scientific Diagram
A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancer - Gynecologic Oncology
